Denosumab Disease Interactions
There are 2 disease interactions with denosumab:
Denosumab (Includes Denosumab) ↔ Hypocalcemia
Severe Potential Hazard, Moderate plausibility
Applies to: Hypocalcemia, Hypoparathyroidism, Thyroid Disease, Renal Dysfunction
Preexisting hypocalcemia must be corrected prior to initiating treatment with denosumab. Caution should be exercised in patients predisposed to hypocalcemia and any disturbances of mineral metabolism, such as history of hypoparathyroidism, thyroid or parathyroid surgery, malabsorption syndromes, excision of small intestine, severe renal impairment or dialysis. Clinical monitoring of calcium and mineral levels (phosphorus and magnesium) are highly recommended within 14 days of denosumab injection. It is important to maintain calcium levels with adequate calcium and vitamin D supplementation.
Denosumab (Includes Denosumab) ↔ Immunosuppression
Moderate Potential Hazard, Moderate plausibility
Applies to: Immunodeficiency
Denosumab should be used with caution in patients with impaired immune systems or taking concomitant immunosuppressant agents as they may be at increased risk for serious infections.
denosumab drug Interactions
There are 214 drug interactions with denosumab
Drug Interaction Classification
|Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.|
|Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.|
|Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.|
|No information available.|
Do not stop taking any medications without consulting your healthcare provider.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.